Natco Pharma on Tuesday reported an over six-fold jump in its consolidated net profit to Rs 369 crore in the second quarter ended Sept. 30, 2023.
The Hyderabad-based drug firm had reported a net profit of Rs 57 crore in the July-September period of last fiscal.
Consolidated total revenue rose to Rs 1,061 crore for the period under review, as compared with Rs 453 crore in the year-ago period, Natco Pharma said in a regulatory filing.
The company reported strong performance during the quarter due to growth in formulation exports and increased sales in the domestic agrochemical business, it added.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
